Industry Overview - The Chinese medical artificial intelligence industry has significant growth potential, driven by policy support for rapid development [2] - The market size of China's medical AI is projected to grow from 2.7 billion RMB in 2019 to 8.8 billion RMB in 2023, with a compound annual growth rate (CAGR) of 33.8%. It is expected to reach 315.7 billion RMB by 2033, with a CAGR of 43.1% from 2023 to 2033 [2] Company Capabilities - The company has developed its own foundational large model, the "Xunfei Spark Medical Model X1," which is the only medical deep reasoning model trained entirely on domestically sourced computing power. In real-world testing, its general auxiliary diagnosis accuracy reached 94.0% [3] - As of July 2025, the Xunfei Spark Medical Model achieved further performance upgrades, with the general auxiliary diagnosis accuracy increasing to 95.0%, and other metrics such as health consultation response rate reaching 91.5% [3] Product Matrix and Market Reach - By the end of 2024, the company had provided products and services to over 70,000 grassroots medical institutions across more than 30 provinces and 670 districts, including over 40 of China's top 100 hospitals [4] - The company's revenue from grassroots medical services grew by 52.3% in the first half of 2025, while the revenue from regional management platform solutions surged by 178.1% [4] - The company's To B business saw a 10% revenue decline due to ongoing updates to the large model, while the To C business experienced a 10% revenue growth [4] Revenue Forecast - Projected revenues for 2025, 2026, and 2027 are 850 million RMB, 1.01 billion RMB, and 1.21 billion RMB, respectively, with corresponding price-to-sales (PS) ratios of 10.7x, 9.0x, and 7.5x [5]